Human blood vessel-derived endothelial progenitors for endothelialization of small diameter vascular prosthesis

PLoS ONE

Volumn 4, Issue 11, 2009, Pages

  Ranjan, Amaresh K ^a   Kumar, Umesh ^b   Hardikar, Ashutosh A ^c,e   Poddar, Penkaj ^b   Nair, Prabha D ^d   Hardikar, Anandwardhan A ^a  

^a NATIONAL CENTRE FOR CELL SCIENCE   (India)

^b NATIONAL CHEMICAL LABORATORY   (India)

^c DEENANATH MANGESHKAR HOSPITAL   (India)

^d SREE CHITRA TIRUNAL INSTITUTE FOR MEDICAL SCIENCES AND TECHNOLOGY   (India)

^e ROYAL HOBART HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF; CADHERIN; CD31 ANTIGEN; LEUKOCYTE ANTIGEN; VASCULAR ENDOTHELIAL CADHERIN; VON WILLEBRAND FACTOR;

ARTERY INTIMA PROLIFERATION; ARTICLE; BLOOD VESSEL PROSTHESIS; BYPASS SURGERY; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL EXPANSION; CELL GROWTH; CELL ISOLATION; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; GRAFT FAILURE; GRAFT PATENCY; HUMAN; HUMAN CELL; HYDROPHILICITY; HYDROPHOBICITY; IN VITRO STUDY; MAMMARY ARTERY; MATERIAL COATING; PHENOTYPE; POLITEF IMPLANT; SAPHENOUS VEIN; STEM CELL; SURFACE PROPERTY; SURGICAL TECHNIQUE; THROMBOCYTE; THROMBOSIS; VASCULAR ENDOTHELIUM; ADSORPTION; BIOSYNTHESIS; BLOOD VESSEL; BLOOD VESSEL TRANSPLANTATION; CONFOCAL MICROSCOPY; CYTOLOGY; FLOW CYTOMETRY; IMAGE PROCESSING; METHODOLOGY; PATHOLOGY;

ADSORPTION; ANTIGENS, CD; ANTIGENS, CD31; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; BLOOD VESSELS; CADHERINS; CELL ADHESION; CELL DIFFERENTIATION; ENDOTHELIUM, VASCULAR; FLOW CYTOMETRY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MICROSCOPY, CONFOCAL; STEM CELLS; VON WILLEBRAND FACTOR;

EID: 70450175705     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007718     Document Type: Article

References (54)

1. Okrainec K, Banerjee DK, Eisenberg MJ (2004) Coronary artery disease in the developing world. Am Heart J 148: 7-15.
2. Rihal CS, Raco DL, Gersh BJ, Yusuf S (2003) Indications for coronary artery bypass surgery and percutaneous coronary intervention in chronic stable angina: review of the evidence and methodological considerations. Circulation 108: 2439-2445.
3. Yang ZK, Shen WF, Zhang RY, Kong Y, Zhang JS, et al. (2007) Coronary artery bypass surgery versus percutaneous coronary intervention with drug-eluting stent implantation in patients with multivessel coronary disease. J Interv Cardiol 20: 10-16.
4. Park DW, Yun SC, Lee SW, Kim YH, Lee CW, et al. (2008) Long-term mortality after percutaneous coronary intervention with drug-eluting stent implantation versus coronary artery bypass surgery for the treatment of multivessel coronary artery disease. Circulation 117: 2079-2086.
5. Hannan EL, Racz MJ, Walford G, Jones RH, Ryan TJ, et al. (2005) Long-term outcomes of coronary-artery bypass grafting versus stent implantation. N Engl J Med 352: 2174-2183.
6. Noishiki Y, Tomizawa Y, Yamane Y, Matsumoto A (1996) Autocrine angiogenic vascular prosthesis with bone marrow transplantation. Nat Med 2: 90-93.
7. Noishiki Y, Yamane Y, Tomizawa Y, Okoshi T, Satoh S, et al. (1992) Rapid endothelialization of vascular prostheses by seeding autologous venous tissue fragments. J Thorac Cardiovasc Surg 104: 770-778.
8. Wang ZG, Du W, Li GD, Pu LQ, Sharefkin JB (1990) Rapid cellular luminal coverage of Dacron inferior vena cava prostheses in dogs by immediate seeding of autogenous endothelial cells derived from omental tissue: results of a preliminary trial. J Vasc Surg 12: 168-179.
9. Furukawa KS, Ushida T, Sugano H, Tamaki T, Ohshima N, et al. (2000) Effect of shear stress on platelet adhesion to expanded polytetrafluoroethylene, a silicone sheet, and an endothelial cell monolayer. ASAIO J 46: 696-701.
10. Cikirikcioglu M, Sedelnikov N, Osorio-Da Cruz S, Khabiri E, Donmez Antal A, et al. (2006) Improved neo-endothelialization of small diameter ePTFE grafts with titanium coating. Int J Artif Organs 29: 990-999.
11. Randone B, Cavallaro G, Polistena A, Cucina A, Coluccia P, et al. (2005) Dual role of VEGF in pretreated experimental ePTFE arterial grafts. J Surg Res 127: 70-79.
12. Lu A, Sipehia R (2001) Antithrombotic and fibrinolytic system of human endothelial cells seeded on PTFE: the effects of surface modification of PTFE by ammonia plasma treatment and ECM protein coatings. Biomaterials 22: 1439-1446.
13. Walluscheck KP, Steinhoff G, Kelm S, Haverich A (1996) Improved endothelial cell attachment on ePTFE vascular grafts pretreated with synthetic RGD-containing peptides. Eur J Vasc Endovasc Surg 12: 321-330.
14. Jeschke MG, Hermanutz V, Wolf SE, Koveker GB (1999) Polyurethane vascular prostheses decreases neointimal formation compared with expanded polytetrafluoroethylene. J Vasc Surg 29: 168-176.
15. Bevilacqua S, Alkodami AA, Volpi E, Cerillo AG, Berti S, et al. (2009) Risk stratification after coronary artery bypass surgery by a point-of-care test of platelet function. Ann Thorac Surg 87: 496-502.
16. Saad EM, Kaplan S, el-Massry S, Kaplan A, Marcoe KF, et al. (1993) Platelet aggregometry can accurately predict failure of externally supported knitted Dacron femoropopliteal bypass grafts. J Vasc Surg 18: 587-594; discussion 594-585.
17. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, et al. (2000) Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95: 952-958.
18. Kocher AA, Schuster MD, Szabolcs MJ, Takuma S, Burkhoff D, et al. (2001) Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7: 430-436.
19. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, et al. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science 275: 964-967.
20. Murohara T, Ikeda H, Duan J, Shintani S, Sasaki K, et al. (2000) Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 105: 1527-1536.
21. Shi Q, Rafii S, Wu MH, Wijelath ES, Yu C, et al. (1998) Evidence for circulating bone marrow-derived endothelial cells. Blood 92: 362-367.
22. Planat-Benard V, Silvestre JS, Cousin B, Andre M, Nibbelink M, et al. (2004) Plasticity of human adipose lineage cells toward endothelial cells: physiological and therapeutic perspectives. Circulation 109: 656-663.
23. Majka SM, Jackson KA, Kienstra KA, Majesky MW, Goodell MA, et al. (2003) Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration. J Clin Invest 111: 71-79.
24. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, et al. (2003) Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776.
25. Werner N, Junk S, Laufs U, Link A, Walenta K, et al. (2003) Intravenous transfusion of endothelial progenitor cells reduces neointima formation after vascular injury. Circ Res 93: e17-24.
26. Zengin E, Chalajour F, Gehling UM, Ito WD, Treede H, et al. (2006) Vascular wall resident progenitor cells: a source for postnatal vasculogenesis. Development 133: 1543-1551.
27. Ingram DA, Mead LE, Moore DB, Woodard W, Fenoglio A, et al. (2005) Vessel wall-derived endothelial cells rapidly proliferate because they contain a complete hierarchy of endothelial progenitor cells. Blood 105: 2783-2786.
28. Avci-Adali M, Nolte A, Simon P, Ziemer G, Wendel HP (2009) Porcine EPCs downregulate stem cell markers and upregulate endothelial maturation markers during in vitro cultivation. J Tissue Eng Regen Med.
29. Halama T, Staffler G, Hoch S, Stockinger H, Wolff K, et al. (1999) Vascular-endothelial cadherin (CD144)- but not PECAM-1 (CD31)-based cell-to-cell contacts convey the maintenance of a quiescent endothelial monolayer. Int Arch Allergy Immunol 120: 237-244.
30. Abraham S, Yeo M, Montero-Balaguer M, Paterson H, Dejana E, et al. (2009) VE-Cadherin-mediated cell-cell interaction suppresses sprouting via signaling to MLC2 phosphorylation. Curr Biol 19: 668-674.
31. Ozaki CK, Contreras M, Phaneuf M, Sheppeck RA, Rutter CM, et al. (1995) Platelet activation by healing ePTFE grafts. J Biomed Mater Res 29: 647-653.
32. Sampram ES, Ouriel K (2004) In vitro verification of antithrombotic effect of recombinant soluble nucleotide triphosphate diphosphohydrolase 1. J Vasc Interv Radiol 15: 379-384.
33. Toes GJ, van den Dungen JJ, Haan J, Hermens RA, van Oeveren W (1999) Fluorescence labeling to study platelet and leucocyte deposition onto vascular grafts in vitro. Biomaterials 20: 1951-1958.
34. Cho J, Mosher DF (2006) Impact of fibronectin assembly on platelet thrombus formation in response to type I collagen and von Willebrand factor. Blood 108: 2229-2236.
35. Ni H, Yuen PS, Papalia JM, Trevithick JE, Sakai T, et al. (2003) Plasma fibronectin promotes thrombus growth and stability in injured arterioles. Proc Natl Acad Sci U S A 100: 2415-2419.
36. Matuskova J, Chauhan AK, Cambien B, Astrof S, Dole VS, et al. (2006) Decreased plasma fibronectin leads to delayed thrombus growth in injured arterioles. Arterioscler Thromb Vasc Biol 26: 1391-1396.
37. Appoo J, Norris C, Merali S, Graham MM, Koshal A, et al. (2004) Long-term outcome of isolated coronary artery bypass surgery in patients with severe left ventricular dysfunction. Circulation 110: II13-17.
38. Rasmussen C, Thiis JJ, Clemmensen P, Efsen F, Arendrup HC, et al. (1997) Significance and management of early graft failure after coronary artery bypass grafting: feasibility and results of acute angiography and re-re-vascularization. Eur J Cardiothorac Surg 12: 847-852.
39. Davies AH, Magee TR, Parry R, Horrocks M, Baird RN (1996) Evaluation of distal run-off before femorodistal bypass. Cardiovasc Surg 4: 161-164.
40. Campeau L, Crochet D, Lesperance J, Bourassa MG, Grondin CM (1975) Postoperative changes in aortocoronary saphenous vein grafts revisited: angiographic studies at two weeks and at one year in two series of consecutive patients. Circulation 52: 369-377.
41. Allen BT, Long JA, Clark RE, Sicard GA, Hopkins KT, et al. (1984) Influence of endothelial cell seeding on platelet deposition and patency in small-diameter Dacron arterial grafts. J Vasc Surg 1: 224-233.
42. Bujan J, Bellon JM, Navlet JG, Honduvilla N, Hernando A, et al. (1992) Seeding of expanded polytetrafluoroethylene (ePTFE) vascular grafts. A morphological study of porcine endothelial and fibroblast cells. Histol Histopathol 7: 635-642.
43. Bull HA, Pittilo RM, Drury J, Pollock JG, Clarke JM, et al. (1988) Effects of autologous mesothelial cell seeding on prostacyclin production within Dacron arterial prostheses. Br J Surg 75: 671-674.
44. Graham LM, Brothers TE, Vincent CK, Burkel WE, Stanley JC (1991) The role of an endothelial cell lining in limiting distal anastomotic intimal hyperplasia of 4-mm-I.D. Dacron grafts in a canine model. J Biomed Mater Res 25: 525-533.
45. Graham LM, Burkel WE, Ford JW, Vinter DW, Kahn RH, et al. (1980) Immediate seeding of enzymatically derived endothelium in Dacron vascular grafts. Early experimental studies with autologous canine cells. Arch Surg 115: 1289-1294.
46. Leseche G, Ohan J (1995) Enhanced patency of venous Dacron grafts by endothelial cell sodding. Ann Vasc Surg 9: 325-326.
47. Pasterkamp G, de Kleijn DP, Borst C (2000) Arterial remodeling in atherosclerosis, restenosis and after alteration of blood flow: potential mechanisms and clinical implications. Cardiovasc Res 45: 843-852.
48. Walluscheck KP, Bierkandt S, Brandt M, Cremer J (2005) Infrainguinal ePTFE vascular graft with bioactive surface heparin bonding. First clinical results. J Cardiovasc Surg (Torino) 46: 425-430.
49. Keuren JF, Wielders SJ, Driessen A, Verhoeven M, Hendriks M, et al. (2004) Covalently-bound heparin makes collagen thromboresistant. Arterioscler Thromb Vasc Biol 24: 613-617.
50. Keuren JF, Wielders SJ, Willems GM, Morra M, Cahalan L, et al. (2003) Thrombogenicity of polysaccharide-coated surfaces. Biomaterials 24: 1917-1924.
51. Dalsing MC, Kevorkian M, Raper B, Nixon C, Lalka SG, et al. (1989) An experimental collagen-impregnated Dacron graft: potential for endothelial seeding. Ann Vasc Surg 3: 127-133.
52. Carr HM, Vohra R, Welch M, Rooney OB, Sharma H, et al. (1992) Fibronectin binding to gelatin-impregnated Dacron (Gelseal) prostheses. Artif Organs 16: 342-345.
53. Eskin SG, Navarro LT, O'Bannon W, DeBakey ME (1983) Behavior of endothelial cells cultured on Silastic and Dacron velour under flow conditions in vitro: implications for prelining vascular grafts with cells. Artif Organs 7: 31-37.
54. Foxall TL, Auger KR, Callow AD, Libby P (1986) Adult human endothelial cell coverage of small-caliber Dacron and polytetrafluoroethylene vascular prostheses in vitro. J Surg Res 41: 158-172.